ANALYSIS OF THE RELATIONSHIP BETWEEN MORBIDITY, MORTALITY AND RESTRICTIVE MEASURES IN DIFFERENT COUNTRIES DURING THE COVID-19 PANDEMIC
Introduction: The pandemic of the new coronavirus infection COVID-19 has posed the need for the healthcare system to promptly address the issues of organizing medical care for an increasing flow of patients. The scale of the pandemic has shown that no State has sufficiently demonstrated a high willingness to respond quickly and implement measures to reduce the outbreak of infection.
The purpose of the study: To study morbidity and mortality in terms of the number of restrictive measures taken in different countries during the COVID-19 pandemic.
Materials and methods: For the analysis, open sources of information from the Our World in Data portal were used, where world statistics on the COVID-19 pandemic were collected and systematized. The data analysis period is March 2020 to the present. The analysis includes countries such as the USA, Great Britain, Italy, Canada, India, China, Turkey, Israel, Russia and Kazakhstan. For the analysis, databases on the number of confirmed cases of the disease, the number of confirmed deaths and the severity index of restrictive measures were studied. A Spearman correlation analysis of the dependence of cases of diseases, deaths and Severity Index was carried out.
Results and discussion: On March 11, 2020, the World Health Organization (WHO) announced the COVID-19 pandemic in the world. The incidence of coronavirus began to rise sharply, especially in European countries, despite the fact that there was not enough information about the virus, which caused panic among the world's population. In addition to the increase in morbidity, the level of mortality increased. Since 2020, restrictive measures have been introduced in many countries. It was difficult to assess the effectiveness of the implemented measures immediately. 2 years later, a Severity Index was developed, which took into account all the restrictive measures applied in the countries.
The correlation analysis showed that the analysis of cases of disease and deaths for 04/18/2020 has a strong correlation r=0.732 (differences are statistically significant p=0.002), while the correlation of the Severity Index and deaths has a weak and statistically insignificant relationship (r=-0.067, p=0.814). The correlation analysis of the Severity Index and cases of the disease also have no correlation (r=0.036, p=0.899).
Conclusions: An analysis of the relationship between morbidity, mortality and restrictive measures during the COVID-19 pandemic showed that there was no correlation between the restrictive measures taken during the pandemic and the level of diseases and mortality in the studied countries. There is a direct and strong correlation between the level of diseases and deaths in 2020 and 2022.
Andrey A. Dubitsky1, Aziza T. Mynbayeva1, Zhanara B. Ibrayeva2,
Assel Zh. Baibussinova2 , https://orcid.org/0000-0003-3447-6245
Абрамов А.В., Багдасарян В.Э., Бышок С.О. и др. Пандемия COVID-19: конец привычного мира? Российский социально-гуманитарный журнал. 2020. №2. С. 50-52
2. Данилова И.А. Заболеваемость и смертность от COVID-19. Проблема сопоставимости данных. Демографическое обозрение. 2020. №1.с.6-26
3.Новости Sputnik Казахстан. Два года пандемии COVID-19: хронология событий [Электронный ресурс] https://ru.sputnik.kz/20220311/dva-goda-pandemii-covid-19-khronologiya-sobytiy-23443376.html (дата обращения: 15.10.2023)
4. Песенникова Е.В., Перхов В.И. Направления развития медицины и здравоохранения в постпандемическом мире. Современные проблемы здравоохранения и медицинской статистики. 2020. №4. URL: https://cyberleninka.ru/article/n/napravleniya-razvitiya-meditsiny-i-zdravoohraneniya-v-postpandemicheskom-mire (дата обращения: 12.01.2024)
5. Ahrenfeldt L.J., Otavova M., Christensen K., Lindahl-Jacobsen R. Sex and age differences in COVID-19 mortality in Europe. Wien. Klin. Wochenschr. 2020. 133:1–6.
6. Bauer P., Brugger J., König F., Posch M. An international comparison of age and sex dependency of COVID-19 deaths in 2020: a descriptive analysis. Sci Rep. 2021. 11: 19143.
7. Bienvenu L.A., Noonan J., Wang X., Peter K. Higher mortality of COVID-19 in males: sex differences in immune response and cardiovascular comorbidities. Cardiovasc Res. 2020 Dec 1. 116(14):2197-2206. doi: 10.1093/cvr/cvaa284. PMID: 33063089; PMCID: PMC7665363,
8. Chanana N., Palmo T., Sharma K., Kumar R., Graham B.B., Pasha Q. Sex-derived attributes contributing to SARS-CoV-2 mortality. Am J Physiol Endocrinol Metab. 2020, 319(3):E562-E567. doi:10.1152/ajpendo.00295.2020
9. Chams N., Chams S., Badran R., Shams A., Araji A., Raad M., Mukhopadhyay S., Stroberg E., Duval E.J., Barton L.M., Hajj Hussein I. COVID-19: A Multidisciplinary Review. Front Public Health. 2020 Jul 29;8:383. doi: 10.3389/fpubh.2020.00383
10. Gebhard C., Regitz-Zagrosek V., Neuhauser H.K., Morgan R., Klein S.L. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ 2020.11:29. doi: 10.1186/s13293-020-00304-9.,
11. Gregory Andrew "Covid-19 is no longer a global health emergency, says WHO". The Guardian . Archived from the original on May 5, 2023. (Дата обращения: 5 мая 2023).
12. Global Health 50/50. The COVID‐19 Sex‐Disaggregated Data Tracker. https://globalhealth5050.org/the‐sex‐gender‐and‐covid‐19‐project/. (Accessed September 20, 2022).
13. Jin J.-M., Bai P., He W., Wu F., Liu X.-F., Han D.-M., Liu S., Yang J.-K. Gender Differences in Patients With COVID-19: focus on Severity and Mortality. Front Public Health. 2020. 8:152
14. Li Q., Guan X., Wu P., Wang X., Zhou L., Tong Y., Ren R. etc. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. N Engl J Med. 2020. 382:1199–1207.
15. Mohamed M.S, Moulin T.C, Schiöth H.B. Sex differences in COVID-19: the role of androgens in disease severity and progression. Endocrine. 2021 Jan;71(1):3-8. doi: 10.1007/s12020-020-02536-6. Epub 2020 Nov 11. PMID: 33179220; PMCID: PMC7657570,
16. Ningthoujam R., Khomdram D. WHO statement - "Older people are at highest risk from COVID-19": Should the hypothesis be corroborated or rejected? Med Hypotheses. 2020 Nov. 144:109896. doi: 10.1016/j.mehy.2020.109896. Epub 2020 Jun 16. PMID: 32585464; PMCID: PMC7297172.
17. O’Brien J., Du K.Y., Peng Ch. Incidence, clinical features, and outcomes of COVID-19 in Canada: impact of sex and age. J Ovarian Res. 2020. V.13. 137.
18. Rahman A., Kuddus M.A. Modelling the Transmission Dynamics of COVID-19 in Six High-Burden Countries. Biomed Res Int. 2021 May 27. 2021:5089184. doi: 10.1155/2021/5089184. PMID: 34124240; PMCID: PMC8172286.
19. Raza H.A., Sen P., Bhatti O.A., Gupta L. Sex hormones, autoimmunity and gender disparity in COVID-19. Rheumatol Int. 2021 Aug;41(8):1375-1386. doi: 10.1007/s00296-021-04873-9. Epub 2021 Apr 26. PMID: 33903964. PMCID: PMC8075025
20. Rehman S., Ravinayagam V., Nahvi I., Aldossary H., Al-Shammari M., Amiri M.S.A., Kishore U., Al-Suhaimi E.A. Immunity, Sex Hormones, and Environmental Factors as Determinants of COVID-19 Disparity in Women. Front Immunol. 2021 Aug 18. 12:680845. doi: 10.3389/fimmu.2021.680845. PMID: 34484179; PMCID: PMC8416472
21. Rigby J. WHO declares end to COVID global health emergency (Электронный ресурс). https://news.un.org/en/story/2023/05/1136367. (Дата обращения 5 ноября 2023).
22. Opening remarks by the Director-General at a press briefing on COVID-19 on March 11, 2020. World Health Organization (March 11, 2020). Date accessed: June 27, 2020. Archived July 15, 2020
23. Opening remarks by the Director General at the press briefing on COVID-19 on March 11, 2020. (Электронный ресурс). https://www.who.int/ru/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020 (дата обращения 20.12.2023 г.)
24. Website WHO. Coronavirus infection (COVID-19): evolution of the virus (Электронный ресурс). https://www.who.int/ru/news-room/questions-and-answers/item/sars-cov-2-evolution (Дата обращения 12.01.2024).
25. Website Our World in Data (Электронный ресурс) https://ourworldindata.org/explorers/coronavirus-data-explorer?time=2020-01-20..2022-12-31&uniformYAxis=0&country=USA~BRA~JPN~DEU~KAZ~CAN~IND~ITA~ISR~KGZ~MNG~NOR~RUS~TUR~TKM~GBR~UZB&Metric=Stringency+index&Interval=Cumulative&Relative+to+Population=true&Color+by+test+positivity=false (дата обращения: 15.10.2023)
26. Website WHO. WHO lifts global emergency due to COVID-19. Forbes.ru (May 5, 2023). Retrieved May 5, 2023. Archived May 5, 2023.
27. Website WHO. Statement on the fifteenth meeting of the International Health Regulations (Электронный ресурс) Emergency Committee regarding the coronavirus disease (COVID-19) pandemic. (Дата обращения: 5 мая 2023).
28. Website WHO. The WHO has not declared the Covid-19 pandemic over. (Электронный ресурс). https://www.cbc.ca/news/health/who-pandemic-not-emergency-1.6833321 (Дата обращения 5 ноября 2023).
29. Website Hopkins University, Center for Systems Science and Engineering COVID-19 Dashboard (CSSE). https://www.arcgis.com/apps/opsdashboard/index.html#/bda7594740fd40299423467b48e9ecf6 .
Количество просмотров: 414
Категория статей:
АКТУАЛЬНАЯ ТЕМА - COVID-19
Библиографическая ссылка
Dubitsky A.A., Mynbayeva A.T., Ibrayeva Zh.B., Baibussinova A.Zh. Analysis of the relationship between morbidity, mortality and restrictive measures in different countries during the COVID-19 pandemic // Nauka i Zdravookhranenie [Science & Healthcare]. 2024. Vol.26 (4), pp. 142-151. doi 10.34689/SH.2024.26.4.018Похожие публикации:
ПОСТ-COVID-19-СИНДРОМ: СИМПТОМЫ И ФАКТОРЫ РИСКА
ДОЛГОСРОЧНЫЕ НЕВРОЛОГИЧЕСКИЕ ПРОЯВЛЕНИЯ COVID-19 У ДЕТЕЙ: ОБЗОР ЛИТЕРАТУРЫ
REHABILITATION AFTER COVID-19: THE EXPERIENCE OF FOREIGN COUNTRIES. REVIEW.
ANALYSIS OF THE RELATIONSHIP BETWEEN MORBIDITY, MORTALITY AND RESTRICTIVE MEASURES IN DIFFERENT COUNTRIES DURING THE COVID-19 PANDEMIC
IMPACT OF THE COVID-19 PANDEMIC ON QUALITY OF LIFE AND COVID-19 PSYCHOLOGICAL DESTRUCTION SCALES: ADAPTATION AND VALIDATION OF RUSSIAN VERSION